These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 17238215)

  • 21. Screening performance of congenital heart defects in first trimester using simple cardiac scan, nuchal translucency, abnormal ductus venosus blood flow and tricuspid regurgitation.
    Karadzov Orlic N; Egic A; Damnjanovic-Pazin B; Lukic R; Joksic I; Mikovic Z
    Congenit Heart Dis; 2019 Nov; 14(6):1094-1101. PubMed ID: 31573148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of nuchal translucency for prenatal screening of congenital heart defects: a population-based evaluation.
    Jouannic JM; Thieulin AC; Bonnet D; Houyel L; Lelong N; Goffinet F; Khoshnood B
    Prenat Diagn; 2011 Dec; 31(13):1264-9. PubMed ID: 22028040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study.
    Hyett J; Perdu M; Sharland G; Snijders R; Nicolaides KH
    BMJ; 1999 Jan; 318(7176):81-5. PubMed ID: 9880278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prenatal detection of congenital heart disease in a low risk population undergoing first and second trimester screening.
    Jørgensen DE; Vejlstrup N; Jørgensen C; Maroun LL; Steensberg J; Hessellund A; Jørgensen FS; Larsen T; Shalmi AC; Skibsted L; Zingenberg H; Ekelund C; Tabor A
    Prenat Diagn; 2015 Apr; 35(4):325-30. PubMed ID: 25352400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
    Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural heart defects associated with an increased nuchal translucency: 9 years experience in a referral centre.
    Clur SA; Mathijssen IB; Pajkrt E; Cook A; Laurini RN; Ottenkamp J; Bilardo CM
    Prenat Diagn; 2008 Apr; 28(4):347-54. PubMed ID: 18382996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of nuchal translucency in the screening for congenital heart defects.
    Bruns RF; Moron AF; Murta CG; Gonçalves LF; Zamith MM
    Arq Bras Cardiol; 2006 Sep; 87(3):307-14. PubMed ID: 17057931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fetal nuchal translucency in severe congenital heart defects: experiences in Northern Finland.
    Alanen J; Leskinen M; Sairanen M; Korpimaki T; Kouru H; Gissler M; Ryynanen M; Nevalainen J
    J Matern Fetal Neonatal Med; 2019 May; 32(9):1454-1460. PubMed ID: 29157037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of critical congenital heart defects by nuchal translucency norms.
    Jelliffe-Pawlowski LL; Norton ME; Shaw GM; Baer RJ; Flessel MC; Goldman S; Currier RJ
    Am J Obstet Gynecol; 2015 Apr; 212(4):518.e1-10. PubMed ID: 25448520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome].
    Ducarme G; Graesslin O; Alanio E; Bige V; Gaillard D; Gabriel R
    Gynecol Obstet Fertil; 2005 Oct; 33(10):750-4. PubMed ID: 16139544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype.
    Ghi T; Huggon IC; Zosmer N; Nicolaides KH
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):610-4. PubMed ID: 11844199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening performances of abnormal first-trimester ductus venosus blood flow and increased nuchal translucency thickness in detection of major heart defects.
    Karadzov-Orlic N; Egic A; Filimonovic D; Damnjanovic-Pazin B; Milovanovic Z; Lukic R; Mandic V; Joksic I; Vukomanovic V; Kosutic J; Djuricic S; Mikovic Z
    Prenat Diagn; 2015 Dec; 35(13):1308-15. PubMed ID: 26408089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuchal translucency and cardiac abnormalities in euploid singleton pregnancies.
    Shamshirsaz AA; Salmanian B; Ravangard SF; Shamshirsaz AA; Javadian P; Borgida A; Turner G; Feldman D; Spiel M; Benn P; Campbell WA
    J Matern Fetal Neonatal Med; 2014 Mar; 27(5):495-9. PubMed ID: 23806115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis.
    Makrydimas G; Sotiriadis A; Ioannidis JP
    Am J Obstet Gynecol; 2003 Nov; 189(5):1330-5. PubMed ID: 14634564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers.
    Makrydimas G; Sotiriadis A; Huggon IC; Simpson J; Sharland G; Carvalho JS; Daubeney PE; Ioannidis JP
    Am J Obstet Gynecol; 2005 Jan; 192(1):89-95. PubMed ID: 15672008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuchal translucency and major congenital heart defects in fetuses with normal karyotype: a meta-analysis.
    Sotiriadis A; Papatheodorou S; Eleftheriades M; Makrydimas G
    Ultrasound Obstet Gynecol; 2013 Oct; 42(4):383-9. PubMed ID: 23606595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of congenital heart defects throughout pregnancy; impact of first trimester ultrasound screening for cardiac abnormalities.
    Eleftheriades M; Tsapakis E; Sotiriadis A; Manolakos E; Hassiakos D; Botsis D
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2546-50. PubMed ID: 22712625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of fetuses with increased nuchal translucency.
    Bilardo CM; Müller MA; Pajkrt E
    Curr Opin Obstet Gynecol; 2001 Apr; 13(2):169-74. PubMed ID: 11315872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency.
    Zosmer N; Souter VL; Chan CS; Huggon IC; Nicolaides KH
    Br J Obstet Gynaecol; 1999 Aug; 106(8):829-33. PubMed ID: 10453834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of ductus venosus Doppler in first-trimester screening for major cardiac defects.
    Chelemen T; Syngelaki A; Maiz N; Allan L; Nicolaides KH
    Fetal Diagn Ther; 2011; 29(2):127-34. PubMed ID: 21160164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.